Correlation Between Cumberland Pharmaceuticals and ORACLE

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cumberland Pharmaceuticals and ORACLE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cumberland Pharmaceuticals and ORACLE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cumberland Pharmaceuticals and ORACLE P 65, you can compare the effects of market volatilities on Cumberland Pharmaceuticals and ORACLE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cumberland Pharmaceuticals with a short position of ORACLE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cumberland Pharmaceuticals and ORACLE.

Diversification Opportunities for Cumberland Pharmaceuticals and ORACLE

0.3
  Correlation Coefficient

Weak diversification

The 3 months correlation between Cumberland and ORACLE is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Cumberland Pharmaceuticals and ORACLE P 65 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ORACLE P 65 and Cumberland Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cumberland Pharmaceuticals are associated (or correlated) with ORACLE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ORACLE P 65 has no effect on the direction of Cumberland Pharmaceuticals i.e., Cumberland Pharmaceuticals and ORACLE go up and down completely randomly.

Pair Corralation between Cumberland Pharmaceuticals and ORACLE

Given the investment horizon of 90 days Cumberland Pharmaceuticals is expected to under-perform the ORACLE. In addition to that, Cumberland Pharmaceuticals is 3.29 times more volatile than ORACLE P 65. It trades about 0.0 of its total potential returns per unit of risk. ORACLE P 65 is currently generating about 0.02 per unit of volatility. If you would invest  10,650  in ORACLE P 65 on September 3, 2024 and sell it today you would earn a total of  223.00  from holding ORACLE P 65 or generate 2.09% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy97.95%
ValuesDaily Returns

Cumberland Pharmaceuticals  vs.  ORACLE P 65

 Performance 
       Timeline  
Cumberland Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cumberland Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward indicators, Cumberland Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.
ORACLE P 65 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ORACLE P 65 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, ORACLE is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Cumberland Pharmaceuticals and ORACLE Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cumberland Pharmaceuticals and ORACLE

The main advantage of trading using opposite Cumberland Pharmaceuticals and ORACLE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cumberland Pharmaceuticals position performs unexpectedly, ORACLE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ORACLE will offset losses from the drop in ORACLE's long position.
The idea behind Cumberland Pharmaceuticals and ORACLE P 65 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency